Clinical Focus

• Cancer> Urologic Oncology
• Prostate Cancer - Robotic Prostatectomy
• Bladder Cancer - Robotic Cystectomy
• Urologic Oncology - Prostate, Bladder, Kidney, Testicular Cancer
• Urology

Administrative Appointments

• Director, Robotic-Assisted Urologic Cancer Surgery, Stanford University (2009 - present)

Honors and Awards

• Career Development Award, Prostate Cancer Foundation (2006)
• Gerald P. Murphy Scholar, American Urological Association (2005)
• Alpha Omega Alpha, Johns Hopkins University (2005)
• First Place, Basic Sciences, AUA Mid-Atlantic Resident Prize Essay Competition (2003)
• Irving I. Lasky Award for Most Outstanding Research, USC Keck School of Medicine (1999)

Professional Education

Graduate & Fellowship Program Affiliations

• Urology

Internet Links

• ABC News - Prostate Cancer Q&A

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Current Research Interests

My laboratory is focused on studying the role of DNA methylation in prostate and bladder cancer. Certain genes and their downstream targets may be useful molecular markers for disease detection and prognostication. We are interested in utilizing methylation markers to detect abnormal changes in serum and urine. Clinical Focus: Prostate Cancer - Robotic Prostatectomy; Bladder Cancer - Robotic Cystectomy; Urologic Oncology - Prostate, Bladder, Kidney, Testicular Cancer.

Clinical Trials

• Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Recruiting

Publications

• Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center. Albadine R, Hyndman ME, Chaux A, Jeong JY, Saab S, Tavora F, Epstein JI, Gonzalgo ML, Pavlovich CP, Netto GJ. Hum Pathol. 2012; 43 (2): 254-60
• Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes. Willis DL, Gonzalgo ML, Brotzman M, Feng Z, Trock B, Su LM. BJU Int. 2011
• Editorial comment. Liu JJ, Gonzalgo ML. J Urol. 2011; 185 (1): 35-6
• Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching. Magheli A, Gonzalgo ML, Su LM, Guzzo TJ, Netto G, Humphreys EB, Han M, Partin AW, Pavlovich CP. BJU Int. 2011; 107 (12): 1956-62
• Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder. Wang H, Albadine R, Magheli A, Guzzo TJ, Ball MW, Hinz S, Schoenberg MP, Netto GJ, Gonzalgo ML. Urol Oncol. 2011